Literature DB >> 29852089

Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.

Shaghayegh Anvari1, Shahin Najar-Peerayeh1, Mehrdad Behmanesh2, Bita Bakhshi1.   

Abstract

The aim of this study was to assess the cumulative immunogenicity properties of rZot and rAce combination and their potential ability to increase the clearance rate of pathogenic standard Vibrio cholerae strain in challenge experiments in mice model. The recombinant Zot and Ace proteins were produced and used to raise polyclonal antibodies of anti-Zot and anti-Ace recombinant proteins in rabbit. Six-week female BALB/c mice were immunized with different antigens via oral route. Blood samples were collected, and the total amount of IgG and IgA antibodies against rZot and rAce were measured in blood and stool samples of each immunized mouse. Challenge experiments were done with toxigenic V. cholerae strain. The anti-Zot and anti-Ace IgG titers were significantly higher in immunized mice in comparison with control group. The IgG and IgA titers were higher in the sera of mice immunized by recombinant Ace than in group immunized by rZot, indicating the higher immunogenicity of rAce than rZot. The use of rAce and rZot mixture led to synergistic activities in increasing the level of IgG and IgA in comparison with the use of each protein separately. The clearance rate was significantly higher in different challenge groups than in the control group, and the coherence between rZot and rAce reduced the bacterial shedding significantly. In conclusion, the use of recombinant Zot and Ace mixture can produce the proper amount of IgA and IgG against to toxigenic V. cholerae, reduce bacterial shedding in immunized mice significantly, and be used as a potent candidate in cholera vaccine research.

Entities:  

Keywords:  Ace; Vibrio cholerae; vaccine; zot

Mesh:

Substances:

Year:  2018        PMID: 29852089      PMCID: PMC6183201          DOI: 10.1080/21645515.2018.1469593

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  25 in total

1.  Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines.

Authors:  S Uzzau; R Lu; W Wang; C Fiore; A Fasano
Journal:  FEMS Microbiol Lett       Date:  2001-01-01       Impact factor: 2.742

Review 2.  Review of reported cholera outbreaks worldwide, 1995-2005.

Authors:  David C Griffith; Louise A Kelly-Hope; Mark A Miller
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

3.  Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh.

Authors: 
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

4.  Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.

Authors:  Donna S Cox; Sangeeta Raje; Huanling Gao; Noha N Salama; Natalie D Eddington
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

5.  Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.

Authors:  Xue-Han Zhang; Kong-Wang He; Shu-Xia Zhang; Wei-Cai Lu; Pan-Deng Zhao; Xiao-Ting Luan; Qing Ye; Li-Bin Wen; Bin Li; Rong-Li Guo; Xiao-Min Wang; Li-Xin Lv; Jun-Ming Zhou; Zheng-Yu Yu; Ai-Hua Mao
Journal:  Vaccine       Date:  2011-02-21       Impact factor: 3.641

6.  Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette.

Authors:  M Trucksis; J E Galen; J Michalski; A Fasano; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.

Authors:  M Boustanshenas; B Bakhshi; M Ghorbani
Journal:  J Appl Microbiol       Date:  2012-12-20       Impact factor: 3.772

8.  A single point mutation within the coding sequence of cholera toxin B subunit will increase its expression yield.

Authors:  Bita Bakhshi; Mina Boustanshenas; Masoud Ghorbani
Journal:  Iran Biomed J       Date:  2014-07

9.  Human zonulin, a potential modulator of intestinal tight junctions.

Authors:  W Wang; S Uzzau; S E Goldblum; A Fasano
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

10.  Biological activity of recombinant accessory cholerae enterotoxin (ace) on rabbit ileal loops and antibacterial assay.

Authors:  Shaghayegh Anvari; Shahin Najar Peerayeh; Mehrdad Behmanesh; Mina Boustanshenas
Journal:  Cell J       Date:  2012-12-12       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.